Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02771366Phase 2Completed
Phase 2, randomised, double-blind trial (2 arms), sponsored by University of Florida. Primary endpoint: Change in Cerebral Energy Function in Brain Tissue (MRS) at 22 weeks. Started Nov 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02771366.